The Caudate Nucleus Exhibits Distinct Pathology and Cell Type-Specific Responses Across Alzheimer's Disease
Kana, O. Z.; Postupna, N.; Agrawal, A.; Long, B.; Travaglini, K.; Gabitto, M.; Lai, H.-Y.; Mahoney, J. T.; Xiao, M.; Bajwa, T.; Hulsey-Vincent, H.; Oyaizu, S. L.; Mena, G. E.; Hong, J.; Gelfand, E. C.; Kaplan, E. S.; Ariza, J.; Smith, K. A.; McMillen, D. A.; Chakka, A. B.; Goldy, J.; Melief, E. J.; Barta, S.; Oyama, A.; Ruiz, A.; Pom, C. A.; Ayala, A.; Bixby, M.; Huang, A.; Martin, N.; Cuevas, N. V.; Olsen, P.; Nagra, J.; Chakrabarty, R.; Tieu, M.; Cardenas, T.; Torkelson, A.; Bertagnolli, D.; Guzman, J.; Ferrer, R.; Waters, J.; Grabowski, T. J.; Crane, P. K.; Gatto, N. M.; Miller, J. A.; Hodg
Show abstract
A{beta} presence in the caudate nucleus (Ca) partially defines Thal stage III in Alzheimers disease (AD), but little is known about ADs cellular impact on the region. Leveraging a public basal ganglia taxonomy of cellular populations, we generated a cellular resolution atlas of AD-associated pathological changes in Ca. Unlike cortex, we found that Ca AD pathology is dominated by two key features: phosphorylated tau (pTau)-containing neuropil threads enriched near oligodendrocytes in white matter tracts and amyloid-{beta} diffuse plaques enriched in gray matter. Although AD pathology in affected cortical regions results in neuronal loss, we find no AD-driven reductions in neuron proportions in Ca. However, there were observable changes in multiple cellular populations. Protoplasmic astrocytes and FLT1+/IL1B+ microglia increased in abundance with global pTau levels. We also observe gene expression changes in fast-spiking PTHLH-PVALB interneurons indicative of disrupted signaling pathways and altered intrinsic physiological properties. This work provides a cellular-resolution framework for understanding AD pathology in Ca.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A public resource of single cell transcriptomes and multiscale networks from persons with and without Alzheimer's disease 98%
- Cell-type-specific Alzheimer’s disease polygenic risk scores are associated with distinct disease processes in Alzheimer’s disease 98%
- DNA methylation signatures of Alzheimer's disease neuropathology in the cortex are primarily driven by variation in non-neuronal cell-types 97%
Similar papers in this journal
- Applying high-resolution spatial transcriptomics to characterise the amyloid plaque cell niche in Alzheimer's Disease 97%
- Natural genetic variation determines microglia heterogeneity in wild-derived mouse models of Alzheimer's disease 96%
- Sustained TREM2 stabilization accelerates microglia heterogeneity and Abeta pathology in a mouse model of Alzheimer s disease 96%
Similar papers in this journal
- Diverse human astrocyte and microglial transcriptional responses to Alzheimer's pathology 97%
- Rare genetic variation in Fibronectin 1 (FN1) protects against APOEe4 in Alzheimer's disease 96%
- Dysregulated coordination of MAPT exon 2 and exon 10 splicing underlies different tau pathologies in PSP and AD 96%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.